Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment

Patent No. EP2207597 (titled "Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment") was filed by Lajolla Institute FOR Allergy And Immunology on Sep 18, 2008. The application was issued on Feb 19, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
EUROPEAN OPPOSITIONSNov 19, 2020LEONARD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2207597

LAJOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
Application Number
EP08831796A
Filing Date
Sep 18, 2008
Status
Revoked
Jun 2, 2023
Publication Date
Feb 19, 2020